These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 26165750)
1. Prolyl endopeptidase and dipeptidyl peptidase IV are associated with externalizing and aggressive behaviors in normal and autistic adolescents. Frenssen F; Croonenberghs J; Van den Steene H; Maes M Life Sci; 2015 Sep; 136():157-62. PubMed ID: 26165750 [TBL] [Abstract][Full Text] [Related]
2. Effects of psychological stress on serum prolyl endopeptidase and dipeptidyl peptidase IV activity in humans: higher serum prolyl endopeptidase activity is related to stress-induced anxiety. Maes M; Goossens F; Lin A; De Meester I; Van Gastel A; Scharpé S Psychoneuroendocrinology; 1998 Jul; 23(5):485-95. PubMed ID: 9802123 [TBL] [Abstract][Full Text] [Related]
3. Lower serum activity of prolyl endopeptidase in fibromyalgia is related to severity of depressive symptoms and pressure hyperalgesia. Maes M; Libbrecht I; Van Hunsel F; Lin AH; Bonaccorso S; Goossens F; De Meester I; De Clerck L; Biondi M; Scharpe S; Janca A Psychol Med; 1998 Jul; 28(4):957-65. PubMed ID: 9723150 [TBL] [Abstract][Full Text] [Related]
4. Presence of dipeptidyl peptidase II, dipeptidyl peptidase IV, and prolyl endopeptidase in effusion from patients with serous otitis media. Rao AJ; Hagihara M; Nagatsu T; Yanagita N Biochem Med Metab Biol; 1990 Jun; 43(3):276-82. PubMed ID: 1974452 [TBL] [Abstract][Full Text] [Related]
5. Serum activity of prolyl endopeptidase, but not of dipeptidyl peptidase IV, is decreased by immunotherapy with IFN-alpha in high-risk melanoma patients. Van Gool AR; Van Ojik HH; Kruit WH; Mulder PG; Fekkes D; Bannink M; Scharpé S; Stoter G; Eggermont AM; Maes M; Verkerk R J Interferon Cytokine Res; 2004 Jul; 24(7):411-5. PubMed ID: 15296652 [TBL] [Abstract][Full Text] [Related]
6. Distribution of peptidases in cultured cells from middle ear mucosa: prolyl endopeptidase is localized in fibroblasts and dipeptidyl peptidase IV and II in epithelial cells. Avasarala JR; Naoi M; Sasaki S; Ueda M; Saga S; Suzuki T; Yanagita N; Nagatsu T Biochem Med Metab Biol; 1991 Jun; 45(3):355-8. PubMed ID: 1675574 [TBL] [Abstract][Full Text] [Related]
7. Lower activity of serum peptidases in abstinent alcohol-dependent patients. Maes M; Lin A; Bonaccorso S; Vandoolaeghe E; Song C; Goossens F; De Meester I; Degroote J; Neels H; Scharpé S; Janca A Alcohol; 1999 Jan; 17(1):1-6. PubMed ID: 9895030 [TBL] [Abstract][Full Text] [Related]
8. Components of biological variation in prolyl endopeptidase and dipeptidyl-peptidase IV activity in plasma of healthy subjects. Maes M; Scharpé S; De Meester I; Goossens P; Wauters A; Neels H; Verkerk R; De Meyer F; D'Hondt P; Peeters D Clin Chem; 1994 Sep; 40(9):1686-91. PubMed ID: 7915215 [TBL] [Abstract][Full Text] [Related]
9. Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs. Maes M; De Meester I; Scharpe S; Desnyder R; Ranjan R; Meltzer HY Acta Psychiatr Scand; 1996 Jan; 93(1):1-8. PubMed ID: 8919323 [TBL] [Abstract][Full Text] [Related]
10. Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease. Vojdani A; Bazargan M; Vojdani E; Samadi J; Nourian AA; Eghbalieh N; Cooper EL Clin Diagn Lab Immunol; 2004 May; 11(3):515-24. PubMed ID: 15138176 [TBL] [Abstract][Full Text] [Related]
11. Alterations of prolyl endopeptidase activity in the plasma of children with autistic spectrum disorders. Momeni N; Nordström BM; Horstmann V; Avarseji H; Sivberg BV BMC Psychiatry; 2005 Jun; 5():27. PubMed ID: 15932649 [TBL] [Abstract][Full Text] [Related]
12. Activities of dipeptidyl peptidase II, dipeptidyl peptidase IV, prolyl endopeptidase, and collagenase-like peptidase in synovial membrane from patients with rheumatoid arthritis and osteoarthritis. Kamori M; Hagihara M; Nagatsu T; Iwata H; Miura T Biochem Med Metab Biol; 1991 Apr; 45(2):154-60. PubMed ID: 1679339 [TBL] [Abstract][Full Text] [Related]
13. Serum activities of adenosine deaminase, dipeptidyl peptidase IV and prolyl endopeptidase in patients with fibromyalgia: diagnostic implications. Čulić O; Cordero MD; Žanić-Grubišić T; Somborac-Bačura A; Pučar LB; Detel D; Varljen J; Barišić K Clin Rheumatol; 2016 Oct; 35(10):2565-71. PubMed ID: 27527091 [TBL] [Abstract][Full Text] [Related]
14. Prolyl oligopeptidase and dipeptidyl peptidase II/dipeptidyl peptidase IV ratio in the cerebrospinal fluid in Parkinson's disease: historical overview and future prospects. Nagatsu T J Neural Transm (Vienna); 2017 Jun; 124(6):739-744. PubMed ID: 27503084 [TBL] [Abstract][Full Text] [Related]
15. Serum protease activity in chronic kidney disease patients: The GANI_MED renal cohort. Wolke C; Teumer A; Endlich K; Endlich N; Rettig R; Stracke S; Fiene B; Aymanns S; Felix SB; Hannemann A; Lendeckel U Exp Biol Med (Maywood); 2017 Mar; 242(5):554-563. PubMed ID: 28038565 [TBL] [Abstract][Full Text] [Related]
16. Identification of altered dipeptidyl-peptidase activities as potential biomarkers for unipolar depression. Deng J; Lamb JR; Mckeown AP; Miller S; Muglia P; Guest PC; Bahn S; Domenici E; Rahmoune H J Affect Disord; 2013 Nov; 151(2):667-672. PubMed ID: 23948634 [TBL] [Abstract][Full Text] [Related]
17. Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas. Stremenová J; Mares V; Lisá V; Hilser M; Krepela E; Vanicková Z; Syrucek M; Soula O; Sedo A Int J Oncol; 2010 Feb; 36(2):351-8. PubMed ID: 20043068 [TBL] [Abstract][Full Text] [Related]
18. Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy. Maes M; Capuron L; Ravaud A; Gualde N; Bosmans E; Egyed B; Dantzer R; Neveu PJ Neuropsychopharmacology; 2001 Feb; 24(2):130-40. PubMed ID: 11120395 [TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease. Sun AL; Deng JT; Guan GJ; Chen SH; Liu YT; Cheng J; Li ZW; Zhuang XH; Sun FD; Deng HP Diab Vasc Dis Res; 2012 Oct; 9(4):301-8. PubMed ID: 22388283 [TBL] [Abstract][Full Text] [Related]
20. In vivo inhibition of dipeptidyl peptidase IV activity by pro-pro-diphenyl-phosphonate (Prodipine). De Meester I; Belyaev A; Lambeir AM; De Meyer GR; Van Osselaer N; Haemers A; Scharpé S Biochem Pharmacol; 1997 Jul; 54(1):173-9. PubMed ID: 9296364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]